Exam II- DM, Hormones, Thyroid Flashcards
Raloxifene/ Evista
Class: SERM
MOA: modulates estrogen receptors, inc BD, dec cholesterol without increased risk of E2 cancers
Significantly reduces BCa incidence
PO once daily dosing
SE: hot flashes, arthralgias, myalgias, edema, pruritis, increased risk of DVT
***CI: pregnancy, lactation, Hx of DVT, PE, stroke, retinal vein thrombosis
Calcitonin/ Miacalcin
Produced by parafollicular C cells in thyroid
decreases osteoclasts can activity
Decreases risk spinal fx, possibly hip fx too
Class: synthetic hormone
MOA: increases serum Ca
Indic: osteoporosis Tx
SE: nose bleeds, sinusitis, HA, dizziness, edema, anorexia, diarrhea, rashes
IV and nasal spray routes available
Teriparatide/ Forteo
Class: synthetic PTH analog Indic: females with osteoporosis MOA: activates bone turnover with osteoblasts activation Char: SQ, once daily, up to 24 months SE: nausea, leg cramps, dizziness
Benefits continue after discontinuation
chronic high PTH–> inc risk fx; but daily low dose PTH –> dec risk fx
Denosumab/ Prolia
Monoclonal antibodies, anti-TNF agent
Indic: osteoporosis tx, bone metastasis, RA, MMyeloma, giant cell bone carcinoma
MOA: targets RANK Ligand (usu primary signal for bone remodeling)
Char: SQ q6months
SE: increased susceptibility of infx
Sitagliptin/ Januvia
Class: dipeptidyl peptidase-4 inhibitor (DDP-4)
MOA: prevents DDP-4 breakdown of GLP-1/GIP–> increased insulin, decreased glucagon postparandially
Tends to normalize insulin without risk of hypoglycemia
Approved as monotx or with Met/Sulfonly/TZDs but not with insulin
25/50/100 mg tabs available
100mg once daily
$200-400/ month
T2DM medications and their MOAs
Biguinides (metformin): inhibits liver glucose production
Sulfonylureas: increase insulin secretion
Meglitinides: increased insulin secretion
Alpha- glucoidase inhibitors: delays intestinal glucose absorption
TZDs: decreased insulin resistance
DPP-4 inhibitors: increased postparandial insulin release
Metformin/ glucophage / fortamet
Class: biguanide
MOA: decreases hepatic glucose production, increases skeletal musc insulin sensitivity
when used alone, generally won’t cause hypoglycemia
Similar effects on hba1c as sulfonlureas with modest weight loss
SE: wt loss, abd cramping, nausea (decreased in ExR form), metallic taste, increased risk of B12 deficiency (supplementation recommended), LACTIC ACIDOSIS
CI in pts with renal impairment (creative >1.4/1.5)
500/800/1000mg BID or QD if ExR; $55-100/ month
Alendronate/ Fosamax
Class: bisphosphates
MOA: inhibits osteoclasts
Indic: primary drug to treat osteoporosis (postmenopausal and post corticosteroid tx)
SE: upset stomach, esophageal irritation/erosion, esophagitis, atypical femur fractures, osteonecrosis of jaw, myalgia,
low bioavailability
**Take away from meals! Prevent esophageal Sxs by standing upright for 30-60mins after taking PO. D/c after 5yrs increases risk vertebral fx **
Glipizide/ glyburide/ glimepiride (chlorpropamide, tolbutamide 1st generations)
Class: sulfonlureas
MOA: stimulate beta cells to inc insulin production (partially blocks ATP sensitive K channels, increasing the insulin release stage)
Second generations preferred
SE: hypoglycemia, weight gain
Generally ineffective after 5-10 years of use
Avoid in pts with sulfa allergy**
Glyburide has an increased risk of hypoglycemic events
Char: one AM dose, $4-50/month
Nateglinide (Starlix)
Repaglinide (Prandin)
Class: Meglitinide (non-sulfonylurea secretagogue)
MOA: increased insulin secretion, binds ATP dependent K channels
Prandin better than Starlix, Prandin is equal to sulfonlureas in activity
SE: hypoglycemia, weight gain
Approved for use with metformin, Sulfonylurea
Rapid,y absorbed in GI
TID-QID dosing before each meal, do not take if meals are skipped
No generic available $150-300/month
Rosiglitazone (Avandia)
Pioglitazone (ACTOS)
Class: thiazolidinediones (TZDs)/ glitazones
MOA: increase insulin sensitivity in skeletal muscle, decrease liver glucose production
Dosed once daily, may take 6-14 wks to have effect. Approved as mono therapy or with Sulfonylurea/ metformin
Only ACTOS is approved with insulin
SE: inc risk CHF, MI, dec BMD, inc risk fx, weight gain
*monitor lv fxn tests at 1 month and q3months
$125-200/month
Acarbose (precose)
Miglitol (Glyset)
Class: alpha-glucosidase inhibitors
MOA: inhibits brunch border alpha glucosidase in SI –> inhibited carbohydrate hydrolysis–> delayed glucose abs
Must be taken with each meal
No hypoglycemic risk alone, but inc risk with sulfonylurea/ insulin use
TID-QID $90-125/month
SE: abd pain, diarrhea, flatulence, inc transaminases, hepatic failure (acarbose)
CI: chronic intestinal dz, IBD, colonic ulceration, intestinal obstruction
*incase of hypoglycemia, give GLUCOSE, not sucrose
Pramlintide/ Symlin
Class: synthetic amylin (usu produced with insulin in beta cells)
Indic: Type 1 and 2 diabetics who use insulin
Allows put to use less insulin
Cannot be injected in same vial/syringe as insulin
1st drug for type 1 diabetics since insulin!
Inject at meal times
SE: modest weight loss, nausea (improves with optimal dose)
Exenatide/ Byetta
Class: incretin mimetics, synthetic exedin-4 hormone
Isolated from the Gila monster
Increases insulin secretion
Does not inc risk of hypoglycemia on its own, but can if taken with sulfonylureas
Sildenafil citrate / viagra
Tadalafil/ Cialis
Vardenafil/ Levitra
Class: phosphodiesterase type 5 inhibitor
MOA: increases cyclic GMP in smooth muscle–> inc blood in c.cavernosum
Indic: ED, pulmonary hypertension
SE: cyanopsia, photophobia, HA, flushing, hypotension, glaucoma, stroke, priapism
No erection without stimulation
25/50/100mg tabs available
Take 30mins to 4hrs prior to intercourse, no more than 1 tab qd
CI: nitrites, nitrates, NO, nitroglycerin…. Liver/renal impairment, hypotension, degenerative retinal disorders
Doxazosin (Cardura)
Terazosin (Hytrin)
Tamsulosin (Flomax/Urimax)
Silodosin (Urief)
Alpha blockers
Indic: BPH
All equally effective
SE: weakness, orthostatic hypotension, nasal congestion
Finasteride/ Proscar
Class: type 2 5-a-reductive inhibitor
MOA: decs DHT conversion, anti-androgen if
Indic: BPH, male pattern baldness, prostate CA
SE: dec libido, ED, impotency, depression, breast tenderness, breast swelling
PREGNANT FEMALES SHOULD NOT HANDLE
Leuprolide/ Lupron
Anti- androgenic, anti-estrogen if
Indic: prostate ca, precocious puberty, endometriosis, uterine fibroids, some IVF protocols
GnRH synthetic analog, interrupts T and E2 production
SE: dec libido, impotence, N/V, hot flashes, night sweats, arthralgias, myalgias, osteoporosis
Clomiphene/ Clomid
Class: SERM
Indic: infertility, amenorrhea
MOA: binds estrogen receptor sites –> inc GnRH –> inc LH, FSH –> ovulation stimulation
SE: multiple gestations, vaginal dryness, anxiety, hot flashes
Usual etiology for primary vs secondary vs tertiary hypothyroidism
Primary: autoimmune thyroiditis, iodine deficiency, malnutrition, surgery/ ablation
Secondary: pituitary dysfunction
Tertiary: hypothalamic dysfunction
1 grain equivalent doses for
Armor thyroid
Synthroid
Cytomel
1g= 60mg Armour Thyroid= 100mcg of T4 (Synthroid)= 25mcg of T3 (Cytomel)
Mifepristone/ Mifeprex
synthetic steroid, abortifacient within first 2 mo of Pgx
MOA: progestin antagonist, decreases hCG
85% effective in abortion within the first trimester
often used with Cytotec (prostaglandin E1 analog)
SE: abd pain, cramping, vag bleeding for 9-16 days, N/V, diarrhea, dizziness, fatigue, fever, excessive uterine bleeding
CI: IUD, ectopic pregnancy, Prednisone Tx, hemorrhagic d/o, anticoagulation Tx
Morning after pill
1 dose 1.5mg Levonorgestrel (progestin)
or 2 doses 750microgm q12hrs
Prevents implantation, can obtain same effect by taking multiple OCPs
OR
Ulipristal acetate (Ella)
Class: SPRM
given within 5 days of unprotected sex, inhibits ovulation
Skyla
IUD with 13.5mg Levonorgestrel at implantation
14 mcg/day released
FDA approves 3yrs continued use
Liletta
IUD with 52mg Levonorgestrel
20mcg/day released
5yrs continued use approved
Mirena
IUD with 52mg Levonorgestrel
20mcg/day released
5yrs continued use approved
Paragard
copper, non-hormonal IUD
MOA: impairs sperm mobility, ongoing inflammation decreases implantation
approved for 10 years
Nuvaring
Low dose progestin and E2 release
inserted for 3wks, then removed for 2wk for withdrawal bleed.
decreased efficacy if removed for 3 hours. If removed for 3+ hours, use back-up contraception for 7 days.
SE: vaginitis, HA, leucorrhea, nausea, weight gain
CI in Hx of blood clots or in pt at inc risk of clotting